Improving the lives of our patients.
We work tirelessly to create life changing treatments that help our patients live better and fuller lives.
Learn More
Research & Development
We invest in innovative research and development through our own development or partnerships to best address the unmet needs of patients
Learn More
About Us
We are a privately held pharmaceutical company focused on oncology. Everything we do is to bring the promise of tomorrow to the patients we serve.
Learn More
— Research & Development
Oncology Pipeline
We continue to build our treatment portfolio with a current focus on oncology within the United States.
Learn More— Join Our Team
See a Future at Servier?
Learn more about working at Servier and search our current job openings to see if there is a career opportunity for you.
Learn More
Latest News
We’re pleased to announce the FDA filing acceptance and Priority Review of our supplemental New Drug Application in previously treated IDH1-mutated cholangiocarcinoma
Learn More
We are thrilled to announce that Servier Pharmaceuticals has been named one of Boston Business Journal’s 2021 Best Places to Work. Congratulations to all honorees!
Learn More
Servier Announces FDA Filing Acceptance and Priority Review for TIBSOVO® (ivosidenib tablets) in IDH1-mutated Cholangiocarcinoma
Learn MoreAdobe Stock©Mat Hayward | Adobe Stock©REDPIXEL | Adobe Stock©Gorodenkoff | Adobe Stock©Monkey Business